- HCV coinfection approaches zero in Spain: but cirrhosis and reinfection among gay men are still significant even with high rates of cure
- Future PrEP and new results from PURPOSE 1 and 2: does HIV exposure explain incident cases?
- Once-weekly oral ART: islatravir plus lenacapavir sustains results to week 48
- Liverpool University Drug Interaction website recognised for global impact on research and care
- Dolutegravir/lamivudine vs triple ART have similar efficacy in advanced HIV infection with CD4 <200 and viral load >100,000
- EACS guidelines: Double dose start for oral PrEP – rapid protection in two hours
- EACS guidelines: New format and content includes chemsex
Additional reports from Glasgow 2024 are posted to the EATG website.
https://www.eatg.org/hiv-co-infections-news/?hivnews_tag=hiv-glasgow-2024&order=order_date-DESC
This includes reports from Roger Pebody, Gus Cairns and Keith Alcorn from the previous aidsmap team.
i-Base reports are included at the same link.
References
- HIV Glasgow programme.
https://hivglasgow.org/programme - Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual. Journal of the International AIDS Society: Volume 27, Issue S6. (November 2024).
https://onlinelibrary.wiley.com/toc/17582652/2024/27/S6
This report was first published on 10 November 2024.